NantWorks CEO and leadership

Patrick Soon-Shiong (born July 29, 1952) is a South African-American transplant surgeon, billionaire businessman, bioscientist, and media proprietor. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College. Soon-Shiong has published more than 100 scientific papers and has more than 230 issued patents worldwide on advancements spanning numerous fields in technology and medicine.

Charles Kim is a General Counsel at ImmunityBio; Data Analyst at Globe Life Marketing and Advertising Distributors; and General Counsel at NANTHEALTH, INC. and is based in Los Angeles, California. He has worked as General Counsel at NANTKWEST, INC.; Commercial Finance Consultant at DECADA FINANCIAL GROUP LLC; and Bilingual News Reporter at KTE. Charles attended UCLA between 1991 and 1995, University of California Berkeley, and Loyola Law School.

Outcome focused executive experienced in Strategy, Human Resources, and Corporate Operations working in the biotech, pharmaceutical, health care, and media industry. Skilled in Organizational development, Coaching, Business Process Improvement, Strategic Planning, Operational Efficiencies, and Leadership. Extensive experience partnering with key business leaders to deliver organizational capabilities, talent, and culture. Expertise in integrating people strategies with critical organizational goals including enterprise solutions, maximizing the engagement and effectiveness of leadership and the workforce. Serve as an adviser and member to the BOD and Compensation Committee(s).

Robert Morse is a Chief Financial Officer at NANTWORKS LLC and is based in Los Angeles Metropolitan Area. He has worked as Manager, Strategic and Financial Planning at TRIBUNE MEDIA CO; Senior Vice President at Indymac Bank; and Chief Financial Officer at Pacific Bell Interactive Media. Robert studied at UCLA between 1980 and 1984 and USC Marshall School of Business between 1991 and 1994.

Orang Dialameh is a CTO at NANTWORKS LLC, CEO & Cofounder at ExtoLabs, and Co-founder at Ethernom and is based in Greater Los Angeles Area. He has worked as Systems Engineering Manager/ Lead for Advanced Systems at Lear Astronics; Founder, Cofounder at Tensorcom Inc.; and Founder, CEO-CTO Cofounder at NantVision. Orang studied at UCLA Anderson School of Management between 1982 and 1986.

Commercially savvy technologist and globally recognized intellectual property thought leader strategically focused toward the future of security and trust services for big data systems, trusted distributed computing, secure networking and communications, internet services and machine learning as it pertains to the technology, biotechnology and pharmaceutical industries

Specialties: Much of my technical expertise lies in the areas of information theory, distributed systems, digital signal processing, networked communications, digital security, trusted services, data compression, artificial intelligence, secure data transport, mobile computing platforms and embedded software architectures.

Dr. Volkmar Scharf-Katz is a Chief Data and Solution Architect at NANTWORKS LLC and is based in United States.

Patrick Soon-Shiong (born July 29, 1952) is a South African-American transplant surgeon, billionaire businessman, bioscientist, and media proprietor. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College. Soon-Shiong has published more than 100 scientific papers and has more than 230 issued patents worldwide on advancements spanning numerous fields in technology and medicine.

Patrick Soon-Shiong (born July 29, 1952) is a South African-American transplant surgeon, billionaire businessman, bioscientist, and media proprietor. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College. Soon-Shiong has published more than 100 scientific papers and has more than 230 issued patents worldwide on advancements spanning numerous fields in technology and medicine.

Outcome focused executive experienced in Strategy, Human Resources, and Corporate Operations working in the biotech, pharmaceutical, health care, and media industry. Skilled in Organizational development, Coaching, Business Process Improvement, Strategic Planning, Operational Efficiencies, and Leadership. Extensive experience partnering with key business leaders to deliver organizational capabilities, talent, and culture. Expertise in integrating people strategies with critical organizational goals including enterprise solutions, maximizing the engagement and effectiveness of leadership and the workforce. Serve as an adviser and member to the BOD and Compensation Committee(s).